Mesa Nilda (CIK 1756697) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy UTHR (130 shares), Sell UTHR (130 shares), Sell UTHR (98 shares), Buy UTHR (650 shares), Sell UTHR (258 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 130 | $14,412 |
| 2026-09-15 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 130 | $65,752 |
| 2026-09-15 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 98 | $49,586 |
| 2026-07-13 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 650 | $0 |
| 2026-05-13 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 258 | $150,141 |
| 2025-12-10 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 187 | $90,065 |
| 2025-07-28 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 590 | $0 |
| 2025-06-25 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 645 | $187,044 |
Source: SEC Form 4 filings · as of 2026-09-15